High-Density Lipoprotein Alterations in Type 2 Diabetes and Obesity
Alterations affecting high-density lipoproteins (HDLs) are one of the various abnormalities observed in dyslipidemia in type 2 diabetes mellitus (T2DM) and obesity. Kinetic studies have demonstrated that the catabolism of HDL particles is accelerated. Both the size and the lipidome and proteome of H...
Main Authors: | Damien Denimal, Serge Monier, Benjamin Bouillet, Bruno Vergès, Laurence Duvillard |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/13/2/253 |
Similar Items
-
Cholesterol efflux capacity of high‐density lipoprotein was not associated with cognitive decline and brain structures in older people with diabetes mellitus
by: Yuanyuan Wu, et al.
Published: (2022-11-01) -
MEDI6012: Recombinant Human Lecithin Cholesterol Acyltransferase, High‐Density Lipoprotein, and Low‐Density Lipoprotein Receptor–Mediated Reverse Cholesterol Transport
by: Richard T. George, et al.
Published: (2021-07-01) -
High density lipoprotein: When to rethink too much of a good thing
by: Lily N. Dastmalchi, et al.
Published: (2023-09-01) -
Cholesterol efflux capacity is associated with lipoprotein size and vascular health in mild to moderate psoriasis
by: Alexander R. Berg, et al.
Published: (2023-02-01) -
Measures of high-density lipoprotein function in men and women with severe aortic stenosis
by: Anouar Hafiane, et al.
Published: (2022-05-01)